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A B S T R A C T
Numerous post-Streptococcal syndromes (PSS) have been described in the literature.
The role of antibiotic therapy in the management of PSS is best established with acute rheumatic fever.
We present a patient with streptococcus-associated medium vessel vasculitis with multiple flares
despite immunosuppressive therapy that achieved a sustained remission with long term oral penicillin V
250 mg twice daily.
© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Case presentation
A 63-year-old man was referred to the rheumatology depart-
ment following several months of episodic fevers, rigors, cognitive
dysfunction and asthenia.
One month prior to the onset of these symptoms, new
heamatospermia led to the diagnosis of a Gleason 7 grade prostate
cancer. He had curative robotic prostatectomy with no adjuvant
therapy.
The patient reported paroxysmal episodes of fevers, night
sweats and "fuzzy-headedness". Each episode lasted approximate-
ly two days, with asymptomatic intervals of three to four weeks.
During the most recent episode, a transient rash appeared - the
first time on his inner right thigh (Fig. 1) that his primary care
provider diagnosed as herpes zoster and treated with oral
acyclovir. The rash resolved within 2–3 days.
Two months later, he was admitted for recurrence of the rash on
the same right thigh with systemic symptoms. C-reactive protein
(CRP) was 129 mg/L at this time. Patient was discharged on
Acyclovir. Two days later, he developed right knee monoarthritis
which limited his mobility. He was again evaluated in the
emergency department. Laboratory results included CRP of 23
mg/L, elevated anti-streptolysin O titre (ASOT) of 800 IU/L,
negative blood cultures, negative respiratory viral throat screening
panel, negative HIV 1 and 2 antigen/antibody test, and negative
IgM antibody for Varicella Zoster, cytomegalovirus, Epstein-Barr
and parvovirus. The knee aspirate performed twice during this
admission, showed moderate number of neutrophil polymorphs,
synovial matrix and occasional foamy macrophages. It was
negative for bacterial organisms, herpes simplex virus PCR and
crystal deposition. Three days later, he had a significant improve-
ment and was discharged home.
Ten days later, he was seen in ambulatory follow up in the
Rheumatology department. The patient was white with no known
Mediterranean or Asian ancestry. He had no antecedent history of
polyarthralgia, sicca symptoms or orogenital ulcerations. During
his paroxysmal episodes he denied dysuria, respiratory or
abdominal symptoms. Examination revealed mild residual erythe-
ma on the right thigh and a subtle effusion of the right knee. There
was no lymphadenopathy. Chest and abdominal examinations
were normal. Foot pulses were present. No microangiopathic
phenomena or nail changes were identified. Laboratory evaluation
revealed mildly raised inflammatory markers (CRP 6 mg/L and ESR
24 mm/h), mild neutrophilia (11.2  109/L), lymphopenia (0.4 
109/L) and a uric acid level of 0.41 mmol/L. The remaining
biochemistry results, serum protein electrophoresis, autoimmune
screening tests and other various general pathology investigations
were normal (Table 1).
A plain chest film revealed no focal or interstitial changes. ECG
and transthoracic echocardiogram were normal.
A presumed diagnosis of reactive arthritis secondary to an
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patient reported that his knee pain, swelling erythema had
resolved fully, but he continued to have intermittent rigors, with
the most recent episode two days prior. He again had an
erythematous rash of the anterior right thigh. On this occasion,
the rash was mildly tender and was not associated with
lymphadenopathy (Fig. 2). Erythrocyte Sedimentation Rate (ESR)
was mildly elevated 24 mm/hr, CRP was 123 mg/L and ferritin of
507 ug/L. Microscopic hematuria and proteinuria were present on
urinalysis. Urine protein/creatinine ratio was normal and there
were no casts on microscopy.
Multiple differential diagnoses were considered including
Adult-onset Stills' disease, although the rash was not characteristic
and the lymphopaenia, with only a very modest ferritin rise, would
be uncommon. A periodic fever syndrome was excluded as
subsequent molecular genetic testing was negative and indeed
the majority of these syndromes arise before the third decade. A
paraneoplastic phenomenon secondary to prostate cancer wasFig. 1. First right thigh vasculitic rash.
able 1
eneral pathology tests.
Test Result Ref Range & Units
Urea & Electrolytes
Serum sodium 140 136145 mmol/L
Serum potassium 4.1 3.55.1 mmol/L
Serum urea 5.8 2.88.1 mmol/L
Serum creatinine 83 62106 umol/L
eGFR (MDRD) per 1.73 sq m >60 6090 ml/min
Liver function tests
Serum albumin 40 3552 g/L
Serum total protein 71 6687 g/L
Serum globulin 30 1836 g/L
Serum alkaline phosphatase 70 40129 iu/L
Serum total bilirubin 6 021 umol/L
Serum ALT 15 041 iu/L
Bone profile (serum)
Serum calcium 2.30 2.22.55 mmol/L
Serum adjusted calcium 2.30 2.22.55 mmol/L
Serum phosphate 0.71 0.871.45 mmol/L
Serum ferritin 507 30400 Ug/L
Prolactin serum 276 86324 miu/L
Serum cortisol 129 nmol/L
Serum LDH 249 240480 iu/L
Clotting screening
INR 1.0 0.81.2
APTT ratio 1.0 0.81.2
Fibrinogen 7.8 1.84.5 g/L
Serum Creatinine Kinase (CK) 35 39308 iu/L
Thyroid function tests
Serum free thyroxine 13.1 1222 pmol/L
Serum TSH 3.26 0.274.2 mu/L
Serum ACE (angiotensin converting enzyme) 27 852 u/L
PSA (Serum prostate – specific Ag) 0.34 041 ug/L
Serum protein electrophoresis
Serum immunoglobulin G 8.9 716 g/L
Serum immunoglobulin A 2.0 0.74 g/L
Serum immunoglobulin M 0.9 0.42.3 g/L
Serum total protein 65 6687 g/L
Comment for SPE Paraprotein band not detectedSerum light chains
Serum Kappa light chains 14 319 mg/L
Serum Lambda light chains 9 629 mg/L
Serum Kappa: Lambda ratio 1.56 0.261.65
CD 4 + 8
CD4 37 2857 %
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range and oncology follow ups confirm that the cancer was in
remission. Reactive phenomena related to an unclear infective
agent remained the main differential diagnosis.
ASOT was 1600 IU/L (Fig. 3) on this occasion. The increasing
ASOT suggested that the patient has been infected with Group
A streptococcus in the preceding months. However, the
chronology of ASOT levels did not initially appear to correlate
with symptoms, nor was there evidence of active streptococcal
infection. As such, antimicrobial therapy was not initiated.
Group A streptococcus would be an unlikely urinary pathogen,
as it is not normally associated with urinary tract infections or
urogenital surgery. Further infectious disease investigations
were normal (Table 1).
A punch biopsy from the thigh skin rash revealed an acute
medium vessel vasculitis with some fat necrosis. A diagnosis of
cutaneous polyarteritis nodosa (cPAN) was suspected. CT-angio-
gram was normal, the patient was normotensive, had no painful
skin nodules, neuropathy, or orchitis and was hepatitis B negative,
suggesting systemic PAN would be unlikely. improvement. However, when tapered below 5 mg prednisolone a
CD4 (abs) 570 200900 10^6/L
CD8 16 1039 %
CD8 (abs) 248 200900 10^6/L
B&T CELL COUNT
T cell (abs) 1233 7002100 10^6/L
B cell 7 619 %
B cell (abs) 123 100500 10^6/L
NK cell 18 731 %
NK cell (abs) 295 90600 10^6/L
T cell 74 5583 %
Urine electrophoresis
Urine protein electrophoresis No evidence of abnormal light chains





Serum C3 1.58 0.811.57 g/L
Serum C4 0.36 0.130.39 g/L
Anti –nuclear antibody (ANA) negative negative
Extractable nuclear antigen autoantibodies (ENA) negative negative
Rheumatoid factor (RF) 12 014 iu/mL
Anti –CCP antibodies (anti-citrullinated proten antibodies) 1.1 07 u/mol
Infection screen
B. Burgdorferi IgM Negative
B. Burgdorferi Ig G Negative
Tropheryma Whippley PCR serology Negative
Throat swab culture Negative
Hepatitis B surface antigen Negative
Hepatitis C antibody Negative
Hepatitis A IgM Negative
Pneumococcal Ig G 34.78 mg/L 30 mg/L
Enteric pathogens (faeces)
Salmonella species DNA Not detected
Shigella species DNA Not detected
Campylobacter species DNA Not detected
VTEC DNA Not detected
Microscopy (Concentrate) Pathogenic parasites not seen
C. parvuum/C. hominis DNA Not detected
Giardia Lamblia DNA Not detected
Fig. 2. Recurrent right thigh vasculitic rash.A repeat skin biopsy during a further episode a month later
revealed marked neutrophilic infiltration of small artery walls,
however no fibrinoid necrosis was present. Given the vasculitic
nature of the skin rash, the patient was treated with oral
prednisolone 30 mg daily for two weeks followed by a tapering
regime within the following months. This lead to a significant3
day the systemic symptoms and rash recurred. Remission of
symptoms was eventually achieved and maintained with 10 mg
daily of prednisolone.
Hydroxychloroquine (HCQ) was added at 200 mg twice a day as
a steroid-sparing agent. He required 7.5 mg prednisolone every
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atient was admitted with a flare of symptoms. CRP was 72 mg/L
nd ASOT was 400 IU/mL. Group C streptococcus (S. dysgalactiae)
as identified in a blood culture. He received 8 hourly intravenous
o-amoxiclav 1.2 g for two days followed by 6 hourly oral
lindamicin 450 mg for 10 days with resolution of all symptoms.
CQ was discontinued due to lack of significant benefit and the
atient was advised to reduce the prednisolone by 1 mg every
onth.
Six months later he was re-admitted with similar symptoms.
urther blood cultures were negative. Positron Emission Tomog-
aphy with FDG tracer (FDG PETCT) revealed increased uptake in
he colon, however targeted biopsies were normal. No uptake was
dentified on the heart valves and repeat transthoracic echocardi-
graphy was not suggestive of infective endocarditis.
Several months later, another flare lead to hospitalization and
lood cultures on this occasion revealed Group B streptococcus (S.
galactiae). He was treated again with 8 hourly intravenous Co-
moxiclav 1.2 g for one day, followed by 8 hourly oral Amoxicillin 1
 for 10 days, resulting in rapid resolution of symptoms.
A diagnosis of streptococcus-associated medium vessel vascu-
itis was made.
The patient was discharged with oral phenoxymethylpenicillin
50 mg twice a day as prophylactic treatment and no further
mmunosuppressive therapies were given. There have been no
urther flares to date following prophylactic antibiotic therapy,
ith the patient reporting full symptom remission for the last 18
onths (Fig.3).
early phase of his illness, however it was difficult to demonstrate
an association. Following the first flare, Group A streptococcus
infection was suspected, but the organism was not recovered on
culture and throat swab. In the majority of post-streptococcal
syndromes there is often a preceding infection that appears within
one to 3 weeks. Only in some occult post streptococcal syndromes
(e.g. movement and neuropsychiatric disorders) has delayed
symptom onset been demonstrated [1].
Following identification of two other streptococci (S. agalactiae
and dysgalactiae) during subsequent admissions with continued
elevated ASOT, suspicion increased for an infective precipitant. It
was particularly notable that during repeated admissions empiric
antibiotic therapy would achieve a prompt resolution of symp-
toms. With penicillin antibiotic prophylaxis alone, the patient
achieved remission without the need for ongoing immunosup-
pressive therapy.
The role of antibiotic therapy in the management of post-
Streptococcal syndromes (PSS) is best established with acute
rheumatic fever. The role of penicillin prophylaxis has been
suggested in paediatric cases of streptococcus associated cPAN [2–
7]. The same prophylactic treatment was also suggested when a
few adult streptococcus related cPAN have been reported but those
cases have had the first vasculitis attack during childhood [8,9].
Our case is different because the patient developed streptococcus
related medium vessel vasculitis in adult life.
With respect to the length of the penicillin prophylactic
treatment duration for streptococcus related recurrent cPAN there
isn’t a consensus approach. Some authors recommend a similar
approach to the rheumatic fever [2]. At the time of their
Fig. 3. Clinical course corroborated with ASOT levels and blood cultures.iscussion
Several years, were required to reach optimal management in
his case of relapsing medium size vessel vasculitis manifesting
ith periodic skin involvement and systemic symptoms. A
uspected relationship with infection was considered from the4
publication some reported good results with penicillin prophylaxis
up to 2 years and as long as up 25 years [6,7]. Others recommended
a lifelong penicillin prophylaxis [8].
For our patient we plan to continue with penicilline V 250 mg
twice daily as prophylaxis for a total of two years. Following this we
will instigate active surveillance for any flares. In case of flares,
R. Saad, K. Tsoi, I.A. Onac et al. IDCases 24 (2021) e01071depending on their intensity (moderate or severe) we may prolong
the prophylactic period up to 5 years or indeed lifelong if required.
This case is also unique by virtue of relapsing vasculitis being
associated with different types of streptococcus (S agalactiae and
dysgalactiae) infection without an identifiable source. Acquired or
genetically-determined immunodeficiency was clearly a possibili-
ty to consider. However, the patient was found to have a normal
serum protein electrophoresis and immunoglobulin levels. B and T
lymphocyte subset analysis, complement levels, and Pneumococ-
cal IgG titre were all normal, as was his spleen size and structure.
The clinical picture was not compatible with inherited
complement deficiency as our patient had no recurrent infections
in childhood. Inherited C1q deficiency, for example, is typically
associated with severe SLE presenting also in childhood, not with
adult onset vasculitis [10].
Leucocyte adhesion deficiency is typically associated with
recurrent pyogenic infection, but also presents in infancy or
childhood.
However, it is known that the type of capsular polysaccharide
(CPS) found on Group B streptococci and also S. suis, notably the
presence of terminal sialic acid, has in itself an immunosuppres-
sive effect, particularly on dendritic cell function [11]. This may be
relevant to the pathophysiology of both the recurrent infections,
and the associated inflammatory disease observed in this case.
Learning points/take home messages
 For relapsing medium vessel vasculitis of uncertain aetiology,
thorough investigations for associated Streptococcal infections
are warranted.
 The diagnosis of Streptococcus-Associated Medium Vessel
Vasculitis can be challenging. The exact temporal relationship
between the inciting infection and the vasculitis onset is unclear
but we suspect it can be variable (days, weeks or months).
 Antibiotic prophylaxis should be considered in relapsing post-
Streptococcal vasculitis, particularly if immunosuppressive
treatment alone is unsuccessful.
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